CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,120 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,461 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 2,287 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 2,509 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 598 shares (to pay taxes)
- 4 Shares withheld for taxes Chairman & CEO gave up 1,922 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 303 shares (to pay taxes)
- 4 Grant or award Chief Operating Officer acquired 1,838 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- CT ORDER Other Confidential Order
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
Page 26 of 39 · 778 filings